DEF 14A: Fortrea Holdings Inc. Announces 2024 Annual Meeting of Stockholders, Outlines Key Proposals

Fortrea Holdings Inc. is set to hold its 2024 Annual Meeting of Stockholders on May 14, 2024, featuring proposals for director elections, auditor ratification, and executive compensation advisory votes.

Summary

• Fortrea Holdings Inc. will hold its Annual Meeting of Stockholders on May 14, 2024, at The Mayton Inn in Cary, North Carolina.
• Stockholders of record as of March 20, 2024, are entitled to vote.
• The meeting will address the election of Edward Pesicka and David Smith as Class I Directors, ratification of Deloitte & Touche LLP as the independent accounting firm, an advisory vote on executive compensation, and a vote on the frequency of future executive compensation votes.
• The Board recommends voting for the director nominees, ratifying the auditor appointment, approving executive compensation, and holding advisory votes on executive compensation annually.
• As of the record date, there were 89,374,032 shares of Common Stock outstanding and entitled to vote at the Annual Meeting.

Sentiment

Score: 7

Explanation: The document is neutral in tone, providing necessary information for the annual meeting. It highlights both positive aspects (recommendations, multiple voting options) and potential risks (forward-looking statements), resulting in a balanced sentiment.

Positives

• The Board is actively soliciting stockholder input on key governance matters.
• The company is providing multiple avenues for stockholders to vote, including phone, internet, and mail.
• The Board recommends a clear voting strategy on all proposals.
• The company is committed to transparency by making proxy materials available online.

Risks

• Forward-looking statements are subject to risks and uncertainties, as detailed in Fortrea's Annual Report on Form 10-K.
• The division of the Board into three classes with staggered terms ending at the 2028 Annual Meeting may delay or prevent a change of our management or a change in control of our Company.

Future Outlook

Fortrea undertakes no obligation to revise or update any forward-looking statements made in this proxy statement, whether as a result of new information, future events or circumstances, or otherwise, except as required by law.

Industry Context

Fortrea is positioned as a leading global provider of clinical development and patient access solutions to the life sciences industry, competing with other contract research organizations (CROs).

Related Party Transactions

• In order to govern the ongoing relationships between us and Labcorp after the Spin and to facilitate an orderly transition, we and Labcorp entered into the Separation and Distribution Agreement as well as other agreements, including a Transition Services Agreement, a Tax Matters Agreement and an Employee Matters Agreement, which are described on the Company Form 8-K filed with the SEC on July 3, 2023.

Stakeholder Impact

• Shareholders are provided with information and a platform to vote on key company decisions.
• Employees are indirectly impacted through decisions on executive compensation and company performance.
• Customers and suppliers may be affected by the overall strategic direction and governance of the company.

Next Steps

• Stockholders are urged to vote their shares by phone, internet, or mail.
• The Board will consider the outcome of the advisory vote on executive compensation when making future decisions.
• The company will report the final results in a Current Report on Form 8-K, which we intend to file with the SEC after the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Executive Compensation, Director Election, Auditor Ratification, Fortrea